Table 2 Mean QLQ-PR25 values of the brachytherapy group after 51 months compared to the long-term follow-up after 141 months. There are two columns for the first follow-up, the first one shows only the (4.3-year) results for patients alive after long-term follow-up; the second shows the results for all patients

Urinary-related symptoms

25.6 (SD = 19.1; n = 79)

29.7 (SD = 23.7; n = 240)

24.3 (SD = 21.8; n = 79)

Bowel-related symptoms

7.3 (SD = 14.1; n = 74)

8.2 (SD = 13.4; n = 223)

8.5 (SD = 12.3; n = 73)

Hormone treatment-related symptoms

11.2 (SD = 11.6; n = 74)

15.5 (SD = 16.1; n = 230)

14.7 (SD = 16.0; n = 76)

Sexual activity

51.1 (SD = 29.1; n = 76)

45.5 (SD = 32.4; n = 234)

40.5 (SD = 31.2; n = 74)

Sexual function

61.6 (SD = 19.3; n = 58)

57.5 (SD = 23.7; n = 154)

64.5 (SD = 23.1; n = 34)

Bother due to use of an incontinence aid

50 (SD = 45.9; n = 6)

43.4 (SD = 38.6; n = 33)

66.7 (SD = 36; n = 13)

Incontinence^a

7.5%

12.9%

16.3%